AAAAAA

   
Results: 1-25 | 26-33 |
Results: 26-33/33
PREVENTION OF GRAFT-VERSUS-HOST DISEASE ON AN INDIVIDUAL BASIS
Authors: ASCHAN J RINGDEN O ANDSTROM E LJUNGMAN P REMBERGER M
Citation: J. Aschan et al., PREVENTION OF GRAFT-VERSUS-HOST DISEASE ON AN INDIVIDUAL BASIS, Transplantation proceedings, 26(3), 1994, pp. 1823-1824
LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING T-CELL DEPLETION WITH A COMBINATION OF METHOTREXATE AND CYCLOSPORINE IN ADULT LEUKEMIC MARROW TRANSPLANT RECIPIENTS
Authors: REMBERGER M RINGDEN O ASCHAN J LJUNGMAN P LONNQVIST B MARKLING L
Citation: M. Remberger et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING T-CELL DEPLETION WITH A COMBINATION OF METHOTREXATE AND CYCLOSPORINE IN ADULT LEUKEMIC MARROW TRANSPLANT RECIPIENTS, Transplantation proceedings, 26(3), 1994, pp. 1829-1830
LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING T-CELL DEPLETION WITH A COMBINATION OF METHOTREXATE AND CYCLOSPORINE IN ADULT LEUKEMIC MARROW TRANSPLANT RECIPIENTS
Authors: RINGDEN O REMBERGER M ASCHAN J LJUNGMAN P LONNQVIST B MARKLING L
Citation: O. Ringden et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING T-CELL DEPLETION WITH A COMBINATION OF METHOTREXATE AND CYCLOSPORINE IN ADULT LEUKEMIC MARROW TRANSPLANT RECIPIENTS, Transplantation, 58(8), 1994, pp. 887-891
LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING T-CELL DEPLETION WITH A COMBINATION OF METHOTREXATE AND CYCLOSPORINE IN ADULT LEUKEMIC MARROW TRANSPLANT RECIPIENTS
Authors: RINGDEN O REMBERGER M ASCHAN J LJUNGMAN P LONNQVIST B MARKLING L
Citation: O. Ringden et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING T-CELL DEPLETION WITH A COMBINATION OF METHOTREXATE AND CYCLOSPORINE IN ADULT LEUKEMIC MARROW TRANSPLANT RECIPIENTS, Transplantation, 58(8), 1994, pp. 887-891
LONG-TERM IMMUNITY TO MEASLES, MUMPS, AND RUBELLA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: LJUNGMAN P LEWENSOHNFUCHS I HAMMARSTROM V ASCHAN J BRANDT L BOLME P LONNQVIST B JOHANSSON N RINGDEN O GAHRTON G
Citation: P. Ljungman et al., LONG-TERM IMMUNITY TO MEASLES, MUMPS, AND RUBELLA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(2), 1994, pp. 657-663
INFLUENZA-A IN IMMUNOCOMPROMISED PATIENTS
Authors: LJUNGMAN P ANDERSSON J ASCHAN J BARKHOLT L EHRNST A JOHANSSON M WEILAND O
Citation: P. Ljungman et al., INFLUENZA-A IN IMMUNOCOMPROMISED PATIENTS, Clinical infectious diseases, 17(2), 1993, pp. 244-247
INCREASED RISK OF RELAPSE IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA GIVEN T-CELL DEPLETED MARROW COMPARED TO METHOTREXATE COMBINED WITHCYCLOSPORINE OR MONOTHERAPY FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE
Authors: ASCHAN J RINGDEN O SUNDBERG B KLAESSON S LJUNGMAN P LONNQVIST B
Citation: J. Aschan et al., INCREASED RISK OF RELAPSE IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA GIVEN T-CELL DEPLETED MARROW COMPARED TO METHOTREXATE COMBINED WITHCYCLOSPORINE OR MONOTHERAPY FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE, European journal of haematology, 50(5), 1993, pp. 269-274
FOSCARNET AS INPATIENT PROPHYLAXIS ONLY IS INSUFFICIENT TO PREVENT CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION
Authors: LONNQVIST B ASCHAN J RINGDEN O
Citation: B. Lonnqvist et al., FOSCARNET AS INPATIENT PROPHYLAXIS ONLY IS INSUFFICIENT TO PREVENT CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION, The Journal of infectious diseases, 168(4), 1993, pp. 1073-1073
Risultati: 1-25 | 26-33 |